Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
19m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
51m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
51m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
52m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
52m agoFirst Quantum Minerals Reports First Quarter 2026 Results
Seres Therapeutics Inc logo

Seres Therapeutics Inc

About

Seres Therapeutics Inc (NASDAQ:MCRB) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 20 2026
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
Apr 9 2026
Seres Therapeutics to Present at CARB-X Investor Day
Mar 12 2026
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 2 2026
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
Feb 12 2026
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases

Financials

Revenue
$789 K
Market Cap
$88.86 M
P/E Ratio
14.48
EPS
0.64

Community Chat

Ask AI

6ix6ixAIEvents